benazepril ๐Ÿถ Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
angiotensin-converting enzyme inhibitors 299 86541-75-5

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • benazepril
  • cibacen
  • benazepril hydrochloride
  • benazepril HCl
prodrug of benazeprilat inhibit angiotensin-converting enzyme (ACE) and results in decreased plasma angiotensin II, which leads to decreased vasopressor activity and to decreased aldosterone secretion
  • Molecular weight: 424.50
  • Formula: C24H28N2O5
  • CLOGP: 1.82
  • LIPINSKI: 0
  • HAC: 7
  • HDO: 2
  • TPSA: 95.94
  • ALOGS: -4.61
  • ROTB: 10

  • Status: OFP

  • Legend:
    OFP - off patent
    OFM - off market
    ONP - on patent

Drug dosage:

DoseUnitRoute
7.50 mg O

ADMET properties:

PropertyValueReference
BDDCS (Biopharmaceutical Drug Disposition Classification System) 1 Benet LZ, Broccatelli F, Oprea TI
S (Water solubility) 78 mg/mL Benet LZ, Broccatelli F, Oprea TI
EoM (Fraction excreted unchanged in urine) 0.50 % Benet LZ, Broccatelli F, Oprea TI
MRTD (Maximum Recommended Therapeutic Daily Dose) 3.13 ยตM/kg/day Contrera JF, Matthews EJ, Kruhlak NL, Benz RD
BA (Bioavailability) 18 % Kim MT, Sedykh A, Chakravarti SK, Saiakhov RD, Zhu H

Approvals:

DateAgencyCompanyOrphan
June 25, 1991 FDA US PHARMS HOLDINGS I

FDA Adverse Event Reporting System (Female)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Angioedema 142.96 12.65 111 16890 37565 50550558
Cerebrovascular accident 117.99 12.65 152 16849 94528 50493595
Coronary artery disease 107.17 12.65 85 16916 29641 50558482
Myocardial infarction 104.81 12.65 139 16862 88888 50499235
Cardiac failure congestive 95.11 12.65 129 16872 84253 50503870
Off label use 55.36 12.65 47 16954 474379 50113744
Drug ineffective 50.68 12.65 127 16874 819206 49768917
Maternal exposure during pregnancy 42.10 12.65 3 16998 159775 50428348
Transient ischaemic attack 40.50 12.65 52 16949 32158 50555965
Chest pain 39.59 12.65 140 16861 176742 50411381
Contraindicated product administered 38.67 12.65 3 16998 148955 50439168
Blood pressure inadequately controlled 36.31 12.65 21 16980 4359 50583764
Swollen tongue 34.09 12.65 45 16956 28585 50559538
Drug intolerance 33.29 12.65 16 16985 219088 50369035
Dizziness 33.03 12.65 214 16787 346155 50241968
Mitral valve incompetence 31.62 12.65 34 16967 17437 50570686
Vasodilatation 30.40 12.65 15 16986 2264 50585859
Treatment failure 30.17 12.65 5 16996 137632 50450491
Oropharyngeal swelling 30.02 12.65 11 16990 795 50587328
Carotid artery stenosis 29.74 12.65 19 16982 4712 50583411
Infusion related reaction 29.63 12.65 10 16991 169547 50418576
Product complaint 29.44 12.65 27 16974 11439 50576684
Renal failure 28.82 12.65 90 16911 106543 50481580
Oedema peripheral 28.69 12.65 117 16884 157844 50430279
Arteriosclerosis 28.58 12.65 24 16977 9053 50579070
Angina unstable 28.14 12.65 21 16980 6685 50581438
Systemic lupus erythematosus 26.93 12.65 7 16994 140615 50447508
Kounis syndrome 26 12.65 11 16990 1164 50586959
Cardiac disorder 24.13 12.65 48 16953 42931 50545192
Emotional distress 23.82 12.65 38 16963 28625 50559498
Cardiovascular disorder 23.75 12.65 23 16978 10431 50577692
Glossodynia 23.61 12.65 5 16996 115564 50472559
Injury 23.22 12.65 51 16950 48874 50539249
Exposure during pregnancy 23.21 12.65 6 16995 121009 50467114
Completed suicide 22.61 12.65 96 16905 131793 50456330
Tricuspid valve incompetence 21.62 12.65 24 16977 12746 50575377
Renal injury 21.57 12.65 20 16981 8591 50579532
Reaction to excipient 19.63 12.65 9 16992 1153 50586970
Depression 19.41 12.65 108 16893 165315 50422808
Wound 18.89 12.65 6 16995 105788 50482335
Rhabdomyolysis 18.88 12.65 41 16960 38986 50549137
Blood pressure increased 18.43 12.65 91 16910 133041 50455082
Gastrooesophageal reflux disease 18.37 12.65 62 16939 76366 50511757
Hyperdynamic left ventricle 18.01 12.65 5 16996 146 50587977
Arteriosclerosis coronary artery 17.72 12.65 17 16984 7619 50580504
Swelling face 17.67 12.65 48 16953 52547 50535576
Fear 17.52 12.65 23 16978 14526 50573597
Gastrointestinal haemorrhage 17.20 12.65 59 16942 73262 50514861
Palpitations 17.14 12.65 70 16931 94436 50493687
Vasoplegia syndrome 16.87 12.65 8 16993 1106 50587017
Dehydration 16.87 12.65 98 16903 152351 50435772
Keratoacanthoma 16.56 12.65 6 16995 420 50587703
Coronary artery occlusion 16.10 12.65 16 16985 7487 50580636
Tendon rupture 14.89 12.65 15 16986 7129 50580994
Rhinitis allergic 14.80 12.65 15 16986 7185 50580938
Blood glucose increased 14.69 12.65 55 16946 71269 50516854
Peripheral vascular disorder 14.28 12.65 13 16988 5454 50582669
Blood urea increased 14.04 12.65 27 16974 23558 50564565
Pyrexia 13.98 12.65 73 16928 380130 50207993
Joint swelling 13.55 12.65 40 16961 245246 50342877
Hiatus hernia 13.46 12.65 23 16978 18321 50569802
C-reactive protein increased 13.32 12.65 3 16998 66471 50521652
Pericarditis 13.12 12.65 5 16996 78684 50509439
Cardiomegaly 13.05 12.65 21 16980 15924 50572199
Laryngeal pain 13.01 12.65 11 16990 4188 50583935
Hyperlipidaemia 12.93 12.65 22 16979 17468 50570655
Haemorrhoids 12.83 12.65 23 16978 19030 50569093
Muscle spasms 12.79 12.65 79 16922 125474 50462649

FDA Adverse Event Reporting System (Male)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Angioedema 193.06 13.42 141 13483 31774 29529129
Myocardial infarction 122.93 13.42 198 13426 110098 29450805
Coronary artery disease 101.35 13.42 113 13511 44077 29516826
Cardiac failure congestive 69.98 13.42 126 13498 76455 29484448
Cerebrovascular accident 67.06 13.42 124 13500 76787 29484116
Off label use 47.99 13.42 41 13583 300759 29260144
Injury 32.58 13.42 42 13582 19004 29541899
Swollen tongue 29.16 13.42 32 13592 12234 29548669
Chest pain 26.55 13.42 112 13512 111861 29449042
Product complaint 26.28 13.42 21 13603 5384 29555519
Emotional distress 25.92 13.42 32 13592 13863 29547040
Blood glucose increased 24.44 13.42 71 13553 58913 29501990
Nodular rash 22.70 13.42 6 13618 104 29560799
Lymphomatoid papulosis 19.52 13.42 6 13618 182 29560721
Blood pressure inadequately controlled 17.79 13.42 12 13612 2374 29558529
Neutropenia 17.45 13.42 21 13603 131690 29429213
Blood gases abnormal 17.09 13.42 6 13618 278 29560625
Carotid artery stenosis 16.85 13.42 15 13609 4454 29556449
Asthenia 16.83 13.42 162 13462 215088 29345815
Shock 16.74 13.42 33 13591 21371 29539532
Pancreatitis 16.72 13.42 44 13580 34470 29526433
Depression 16.30 13.42 80 13544 85067 29475836
Lip swelling 16.16 13.42 24 13600 12386 29548517
Hyperlipidaemia 15.90 13.42 24 13600 12566 29548337
Angina unstable 15.59 13.42 22 13602 10843 29550060
Acute myocardial infarction 15.20 13.42 53 13571 48385 29512518
Dizziness 14.93 13.42 143 13481 189541 29371362
Product use in unapproved indication 14.85 13.42 11 13613 86864 29474039
Fear 14.77 13.42 20 13604 9484 29551419
Toxicity to various agents 14.54 13.42 37 13587 173624 29387279
Type 2 diabetes mellitus 14.54 13.42 24 13600 13557 29547346
Nephrogenic systemic fibrosis 14.41 13.42 13 13611 3929 29556974
Drug interaction 14.35 13.42 45 13579 197340 29363563
Cardiovascular disorder 14.19 13.42 19 13605 8916 29551987
Anxiety 14.12 13.42 77 13547 85288 29475615
General physical health deterioration 14.05 13.42 16 13608 102841 29458062
Lacunar infarction 13.81 13.42 11 13613 2808 29558095
Transient ischaemic attack 13.73 13.42 32 13592 23238 29537665
Pharyngeal oedema 13.70 13.42 15 13609 5719 29555184

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Angioedema 286.25 12.10 214 23887 61607 64413024
Myocardial infarction 234.74 12.10 299 23802 165522 64309109
Coronary artery disease 223.02 12.10 183 23918 60250 64414381
Cerebrovascular accident 178.86 12.10 238 23863 137345 64337286
Cardiac failure congestive 142.91 12.10 208 23893 130372 64344259
Off label use 89.44 12.10 64 24037 632742 63841889
Transient ischaemic attack 50.61 12.10 72 24029 44110 64430521
Chest pain 49.78 12.10 197 23904 235783 64238848
Emotional distress 47.72 12.10 63 24038 35975 64438656
Angina unstable 47.11 12.10 42 24059 15425 64459206
Injury 45.63 12.10 78 24023 55914 64418717
Carotid artery stenosis 42.39 12.10 30 24071 7911 64466720
Swollen tongue 41.57 12.10 58 24043 34896 64439735
Product complaint 41.54 12.10 35 24066 11919 64462712
Cardiac disorder 40.63 12.10 74 24027 55742 64418889
Blood pressure inadequately controlled 37.52 12.10 24 24077 5360 64469271
Cardiovascular disorder 36.67 12.10 37 24064 15844 64458787
Arteriosclerosis 33.07 12.10 35 24066 15842 64458789
Drug abuse 33.05 12.10 5 24096 132369 64342262
Drug intolerance 32.15 12.10 15 24086 187977 64286654
Renal failure 31.54 12.10 143 23958 181545 64293086
Mitral valve incompetence 31.30 12.10 43 24058 25495 64449136
Drug ineffective 30.93 12.10 186 23915 840061 63634570
Depression 30.88 12.10 143 23958 183148 64291483
Contraindicated product administered 29.53 12.10 3 24098 107826 64366805
Neutropenia 29.07 12.10 28 24073 239596 64235035
Hyperlipidaemia 28.63 12.10 39 24062 22937 64451694
Acute myocardial infarction 28.32 12.10 73 24028 69645 64404986
Fear 27.85 12.10 36 24065 20135 64454496
Dizziness 26.96 12.10 262 23839 429901 64044730
Peripheral vascular disorder 26.77 12.10 22 24079 7239 64467392
Maternal exposure during pregnancy 25.41 12.10 3 24098 95881 64378750
Pyrexia 25.37 12.10 115 23986 558529 63916102
Arteriosclerosis coronary artery 25.10 12.10 30 24071 15499 64459132
Vasodilatation 24.95 12.10 15 24086 3003 64471628
Blood pressure increased 24.33 12.10 128 23973 172424 64302207
Infusion related reaction 23.97 12.10 16 24085 164451 64310180
Treatment failure 23.87 12.10 7 24094 116809 64357822
Renal injury 23.62 12.10 29 24072 15400 64459231
Product use in unapproved indication 23.38 12.10 19 24082 176599 64298032
Tricuspid valve incompetence 22.93 12.10 30 24071 16973 64457658
Anxiety 22.47 12.10 141 23960 202508 64272123
Blood glucose increased 22.37 12.10 84 24017 97989 64376642
Shock 22.09 12.10 46 24055 38194 64436437
Lacunar infarction 20.89 12.10 17 24084 5515 64469116
Ventricular hypertrophy 20.45 12.10 18 24083 6498 64468133
Kounis syndrome 19.89 12.10 13 24088 3012 64471619
Exposure during pregnancy 19.23 12.10 3 24098 77672 64396959
Rheumatoid arthritis 19.00 12.10 20 24081 164274 64310357
C-reactive protein increased 18.82 12.10 6 24095 94903 64379728
Palpitations 18.68 12.10 83 24018 104405 64370226
Drug interaction 18.60 12.10 71 24030 362012 64112619
Oropharyngeal swelling 18.51 12.10 9 24092 1182 64473449
Laryngeal pain 18.48 12.10 16 24085 5652 64468979
Pancytopenia 18.25 12.10 16 24085 143293 64331338
Anhedonia 18.20 12.10 24 24077 13682 64460949
Gastrooesophageal reflux disease 17.96 12.10 70 24031 83073 64391558
Coronary artery occlusion 17.95 12.10 24 24077 13867 64460764
Oedema peripheral 17.80 12.10 137 23964 210180 64264451
Nodular rash 17.61 12.10 6 24095 314 64474317
Lymphomatoid papulosis 17.51 12.10 6 24095 320 64474311
Reaction to excipient 17.11 12.10 9 24092 1394 64473237
Cardiomegaly 16.72 12.10 31 24070 23653 64450978
Asthenia 16.66 12.10 238 23863 427806 64046825
Unevaluable event 16.65 12.10 49 24052 50440 64424191
Pancreatitis 16.12 12.10 54 24047 59553 64415078
Myocardial ischaemia 15.88 12.10 30 24071 23221 64451410
Completed suicide 15.68 12.10 140 23961 224274 64250357
Febrile neutropenia 15.55 12.10 29 24072 187628 64287003
Hypertensive heart disease 15.02 12.10 12 24089 3792 64470839
Gastrointestinal haemorrhage 14.61 12.10 92 24009 132220 64342411
Swelling face 14.60 12.10 52 24049 59114 64415517
Hyperdynamic left ventricle 14.25 12.10 5 24096 286 64474345
Atrial fibrillation 14.22 12.10 111 23990 170978 64303653
Type 2 diabetes mellitus 14.20 12.10 36 24065 33984 64440647
Ischaemic cardiomyopathy 14.11 12.10 15 24086 6823 64467808
Electrocardiogram QT prolonged 14.11 12.10 6 24095 79442 64395189
Gastritis 13.71 12.10 41 24060 42577 64432054
Systemic lupus erythematosus 13.56 12.10 6 24095 77606 64397025
Joint swelling 13.26 12.10 39 24062 215343 64259288
Wound 13.22 12.10 6 24095 76471 64398160
Urinary tract stoma complication 13.15 12.10 3 24098 34 64474597
Tendon rupture 13.00 12.10 18 24083 10749 64463882
Neck injury 12.94 12.10 9 24092 2309 64472322
Blood urea increased 12.83 12.10 41 24060 44112 64430519
Thrombocytopenia 12.74 12.10 42 24059 223759 64250872
Therapeutic product effect incomplete 12.64 12.10 12 24089 103470 64371161
General physical health deterioration 12.60 12.10 37 24064 204388 64270243
Lip swelling 12.53 12.10 33 24068 31874 64442757
Pericarditis 12.31 12.10 4 24097 62512 64412119
Rhabdomyolysis 12.21 12.10 67 24034 91659 64382972
Coronary artery surgery 12.16 12.10 4 24097 188 64474443

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC C09AA07 CARDIOVASCULAR SYSTEM
AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
ACE INHIBITORS, PLAIN
ACE inhibitors, plain
ATC C09BA07 CARDIOVASCULAR SYSTEM
AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
ACE INHIBITORS, COMBINATIONS
ACE inhibitors and diuretics
FDA MoA N0000000181 Angiotensin-converting Enzyme Inhibitors
FDA EPC N0000175562 Angiotensin Converting Enzyme Inhibitor
CHEBI has role CHEBI:35457 ACE inhibitor
CHEBI has role CHEBI:50266 Prodrugs
MeSH PA D000806 Angiotensin-Converting Enzyme Inhibitors
MeSH PA D000959 Antihypertensive Agents
MeSH PA D002317 Cardiovascular Agents
MeSH PA D004791 Enzyme Inhibitors
MeSH PA D011480 Protease Inhibitors
FDA PE N0000178477 Decreased Blood Pressure

Drug Use | Suggest Off label Use Form| |View source of the data|

DiseaseRelationSNOMED_IDDOID
Hypertensive disorder indication 38341003 DOID:10763
Chronic heart failure off-label use 48447003
Atrial fibrillation off-label use 49436004 DOID:0060224
Diabetic renal disease off-label use 127013003
Acute scleroderma renal crisis off-label use 236503001
Diastolic heart failure off-label use 418304008 DOID:9775
Hypertension due to Scleroderma off-label use
Nondiabetic Proteinuric Nephropathy off-label use
Anuria contraindication 2472002 DOID:2983
Hypercholesterolemia contraindication 13644009
Hyperkalemia contraindication 14140009
Jaundice contraindication 18165001
Secondary angle-closure glaucoma contraindication 21571006
Hypovolemia contraindication 28560003
Dehydration contraindication 34095006
Hyperuricemia contraindication 35885006 DOID:1920
Angioedema contraindication 41291007 DOID:1558
Hypokalemia contraindication 43339004
Low blood pressure contraindication 45007003
Systemic lupus erythematosus contraindication 55464009 DOID:9074
Sympathectomy contraindication 57071006
Hepatic failure contraindication 59927004
Hypercalcemia contraindication 66931009 DOID:12678
Hyperparathyroidism contraindication 66999008 DOID:13543
Hypochloremic alkalosis contraindication 70134007
Hepatic coma contraindication 72836002 DOID:12550
Diabetes mellitus contraindication 73211009 DOID:9351
Chronic idiopathic constipation contraindication 82934008
Hereditary angioneurotic edema contraindication 82966003 DOID:14735
Hyponatremia contraindication 89627008
Gout contraindication 90560007 DOID:13189
Kidney disease contraindication 90708001 DOID:557
Disorder of connective tissue contraindication 105969002 DOID:65
Liver function tests abnormal contraindication 166603001
Hypomagnesemia contraindication 190855004
Acute pancreatitis contraindication 197456007 DOID:2913
Disease of liver contraindication 235856003 DOID:409
Neonatal hyperbilirubinemia contraindication 281610001
Pregnancy, function contraindication 289908002
Renal artery stenosis contraindication 302233006
Neutropenic disorder contraindication 303011007 DOID:1227
Bone marrow depression contraindication 307762000
Azotemia contraindication 445009001
Intestinal Angioedema contraindication
Head and Neck Angioedema contraindication
Hemodialysis with High-Flux Membrane contraindication
Severe Aortic Valve Stenosis contraindication




๐Ÿถ Veterinary Drug Use

None

๐Ÿถ Veterinary products

ProductApplicantIngredients
Cardalis Ceva Sante Animale 2

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 2.9 acidic
pKa2 5.34 Basic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

TargetClassPharosUniProtActionTypeActivity value
(-log[M])
Mechanism
action
Bioact sourceMoA source
Angiotensin-converting enzyme Enzyme INHIBITOR IC50 6.51 WOMBAT-PK CHEMBL
Angiotensin-converting enzyme Enzyme IC50 8.70 CHEMBL
Angiotensin-converting enzyme Enzyme IC50 8.77 CHEMBL

External reference:

IDSource
4020817 VUID
N0000148336 NUI
D00620 KEGG_DRUG
86541-74-4 SECONDARY_CAS_RN
1546196 RXNORM
C0053091 UMLSCUI
CHEBI:3011 CHEBI
CHEBI:88200 CHEBI
CHEMBL838 ChEMBL_ID
CHEMBL1694 ChEMBL_ID
DB00542 DRUGBANK_ID
C044946 MESH_SUPPLEMENTAL_RECORD_UI
5362124 PUBCHEM_CID
6374 IUPHAR_LIGAND_ID
C052133 MESH_SUPPLEMENTAL_RECORD_UI
6375 IUPHAR_LIGAND_ID
6129 INN_ID
86541-78-8 SECONDARY_CAS_RN
UDM7Q7QWP8 UNII
5463984 PUBCHEM_CID
DB14125 DRUGBANK_ID
1267 MMSL
4251 MMSL
48720 MMSL
d00730 MMSL
003597 NDDF
003598 NDDF
4020025 VANDF
4020817 VANDF
C0105523 UMLSCUI
CHEMBL1192519 ChEMBL_ID
6128 INN_ID
108572003 SNOMEDCT_US
108573008 SNOMEDCT_US
372511001 SNOMEDCT_US
JRM708L703 UNII

Pharmaceutical products:

ProductCategoryIngredientsNDCFormQuantityRouteMarketingLabel
Lotrel HUMAN PRESCRIPTION DRUG LABEL 2 0078-0364 CAPSULE 20 mg ORAL NDA 31 sections
Lotrel HUMAN PRESCRIPTION DRUG LABEL 2 0078-0364 CAPSULE 20 mg ORAL NDA 31 sections
Lotrel HUMAN PRESCRIPTION DRUG LABEL 2 0078-0379 CAPSULE 40 mg ORAL NDA 31 sections
Lotrel HUMAN PRESCRIPTION DRUG LABEL 2 0078-0379 CAPSULE 40 mg ORAL NDA 31 sections
Lotrel HUMAN PRESCRIPTION DRUG LABEL 2 0078-0405 CAPSULE 10 mg ORAL NDA 31 sections
Lotrel HUMAN PRESCRIPTION DRUG LABEL 2 0078-0405 CAPSULE 10 mg ORAL NDA 31 sections
Lotrel HUMAN PRESCRIPTION DRUG LABEL 2 0078-0406 CAPSULE 20 mg ORAL NDA 31 sections
Lotrel HUMAN PRESCRIPTION DRUG LABEL 2 0078-0406 CAPSULE 20 mg ORAL NDA 31 sections
Benazepril Hydrochloride and Hydrochlorothiazide HUMAN PRESCRIPTION DRUG LABEL 2 0185-0211 TABLET, FILM COATED 20 mg ORAL ANDA 22 sections
Benazepril Hydrochloride and Hydrochlorothiazide HUMAN PRESCRIPTION DRUG LABEL 2 0185-0211 TABLET, FILM COATED 20 mg ORAL ANDA 22 sections
Benazepril Hydrochloride and Hydrochlorothiazide HUMAN PRESCRIPTION DRUG LABEL 2 0185-0236 TABLET, FILM COATED 5 mg ORAL ANDA 22 sections
Benazepril Hydrochloride and Hydrochlorothiazide HUMAN PRESCRIPTION DRUG LABEL 2 0185-0236 TABLET, FILM COATED 5 mg ORAL ANDA 22 sections
Benazepril Hydrochloride and Hydrochlorothiazide HUMAN PRESCRIPTION DRUG LABEL 2 0185-0277 TABLET, FILM COATED 20 mg ORAL ANDA 22 sections
Benazepril Hydrochloride and Hydrochlorothiazide HUMAN PRESCRIPTION DRUG LABEL 2 0185-0277 TABLET, FILM COATED 20 mg ORAL ANDA 22 sections
Benazepril Hydrochloride and Hydrochlorothiazide HUMAN PRESCRIPTION DRUG LABEL 2 0185-0325 TABLET, FILM COATED 10 mg ORAL ANDA 22 sections
Benazepril Hydrochloride and Hydrochlorothiazide HUMAN PRESCRIPTION DRUG LABEL 2 0185-0325 TABLET, FILM COATED 10 mg ORAL ANDA 22 sections
benazepril hydrochloride and hydrochlorothiazide HUMAN PRESCRIPTION DRUG LABEL 2 0574-0227 TABLET 10 mg ORAL NDA authorized generic 23 sections
benazepril hydrochloride and hydrochlorothiazide HUMAN PRESCRIPTION DRUG LABEL 2 0574-0228 TABLET 20 mg ORAL NDA authorized generic 23 sections
benazepril hydrochloride and hydrochlorothiazide HUMAN PRESCRIPTION DRUG LABEL 2 0574-0229 TABLET 20 mg ORAL NDA authorized generic 23 sections
Benazepril Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 10544-554 TABLET 20 mg ORAL ANDA 13 sections
Benazepril Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 10544-561 TABLET, FILM COATED 40 mg ORAL ANDA 13 sections
Benazepril Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 10544-566 TABLET 10 mg ORAL ANDA 13 sections
BENAZEPRIL HUMAN PRESCRIPTION DRUG LABEL 1 16590-259 TABLET 20 mg ORAL ANDA 13 sections
Benazepril Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 16590-280 TABLET 10 mg ORAL ANDA 12 sections
Benazepril Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 21695-327 TABLET, FILM COATED 20 mg ORAL ANDA 19 sections
Benazepril Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 21695-612 TABLET, FILM COATED 5 mg ORAL ANDA 19 sections
Amlobenz HUMAN PRESCRIPTION DRUG LABEL 2 21695-866 CAPSULE 10 mg ORAL ANDA 27 sections
Benazepril Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 21695-877 TABLET, FILM COATED 40 mg ORAL ANDA 19 sections
Amlobenz HUMAN PRESCRIPTION DRUG LABEL 2 21695-916 CAPSULE 20 mg ORAL ANDA 27 sections
Lotensin HUMAN PRESCRIPTION DRUG LABEL 1 30698-448 TABLET 10 mg ORAL NDA 26 sections